Altre lingue Aethlon Medical, Inc.

Azioni

AEMD

US00808Y4061

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 05/07/2024			Variaz. 5gg	Var. 1 gen.
0,4505 ^USD	+12,57%		-9,67%	-79,43%

27/06	Aethlon Medical, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 marzo 2024	CI
27/06	Transcript : Aethlon Medical, Inc., 2024 Earnings Call, Jun 27, 2024

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Aethlon Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	27/06
Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update	27/06
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024	21/06
What's Next in Treatments for Cancer Patients with Solid Tumors?	20/06
Aethlon Medical Receives Ethics Committee Approval for Hemopurifier Cancer Trial	19/06
Top Small-Cap Stocks Leading the Market Surge: ASNS, PRSO, RELI, VTAK, AEMD	19/06
Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial	18/06
Aethlon Medical, Inc. Receives Ethics Committee Approval for Hemopurifier® Cancer Trial	18/06
Exploring Top NASDAQ Stocks Under $1 Gaining Traction: KITT, AEMD, VTAK, TELL, KWE	12/06
The Hunt for Virus Treatments Continues Post Covid-19	07/06
Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID	03/06
Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies	03/06
Aethlon Medical, Inc. Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies	03/06
Top Midday Decliners	15/05
Aethlon Medical Announces Pricing of $4.7 Million Public Offering	15/05
Aethlon Medical Reports Positive Results from an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles from Cancer Patient Plasma	13/05
Wall Street Set to Open Higher Monday as Investors Look Toward Key Inflation Figures	13/05
Investors Eye Key Inflation Data in Days Ahead as US Futures Trend Modestly Higher Monday	13/05
Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma	10/05
Aethlon Medical, Inc. Reports Positive Results from an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles from Cancer Patient Plasma	10/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Aethlon Medical, Inc.

Azioni

AEMD

US00808Y4061

Altre lingue

Filtri